130 related articles for article (PubMed ID: 12844533)
41. The genetic and molecular mechanisms of motor neuron disease.
Wong PC; Rothstein JD; Price DL
Curr Opin Neurobiol; 1998 Dec; 8(6):791-9. PubMed ID: 9914243
[TBL] [Abstract][Full Text] [Related]
42. Intracerebroventricular Delivery in Mice for Motor Neuron Diseases.
Nizzardo M; Rizzuti M
Methods Mol Biol; 2017; 1565():229-239. PubMed ID: 28364247
[TBL] [Abstract][Full Text] [Related]
43. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis.
Lowry KS; Murray SS; McLean CA; Talman P; Mathers S; Lopes EC; Cheema SS
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Sep; 2(3):127-34. PubMed ID: 11771768
[TBL] [Abstract][Full Text] [Related]
44. Cell death pathways differ in several mouse models with motoneurone disease: analysis of pure motoneurone populations at a presymptomatic age.
Perrin FE; Boisset G; Lathuilière A; Kato AC
J Neurochem; 2006 Sep; 98(6):1959-72. PubMed ID: 16831193
[TBL] [Abstract][Full Text] [Related]
45. Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration.
Katsuno M; Adachi H; Minamiyama M; Waza M; Tokui K; Banno H; Suzuki K; Onoda Y; Tanaka F; Doyu M; Sobue G
J Neurosci; 2006 Nov; 26(47):12106-17. PubMed ID: 17122035
[TBL] [Abstract][Full Text] [Related]
46. Zebrafish models of human motor neuron diseases: advantages and limitations.
Babin PJ; Goizet C; Raldúa D
Prog Neurobiol; 2014 Jul; 118():36-58. PubMed ID: 24705136
[TBL] [Abstract][Full Text] [Related]
47. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse.
Fujita K; Yamauchi M; Matsui T; Titani K; Takahashi H; Kato T; Isomura G; Ando M; Nagata Y
Brain Res; 1998 Feb; 785(1):31-40. PubMed ID: 9526038
[TBL] [Abstract][Full Text] [Related]
48. Genetically engineered mouse models of neurodegenerative diseases.
Wong PC; Cai H; Borchelt DR; Price DL
Nat Neurosci; 2002 Jul; 5(7):633-9. PubMed ID: 12085093
[TBL] [Abstract][Full Text] [Related]
49. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease.
Lee MK; Marszalek JR; Cleveland DW
Neuron; 1994 Oct; 13(4):975-88. PubMed ID: 7946341
[TBL] [Abstract][Full Text] [Related]
50. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1).
Grohmann K; Rossoll W; Kobsar I; Holtmann B; Jablonka S; Wessig C; Stoltenburg-Didinger G; Fischer U; Hübner C; Martini R; Sendtner M
Hum Mol Genet; 2004 Sep; 13(18):2031-42. PubMed ID: 15269181
[TBL] [Abstract][Full Text] [Related]
51. Axonal involvement in the Wlds neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre-symptomatic age.
Simonin Y; Perrin FE; Kato AC
J Neurochem; 2007 Apr; 101(2):530-42. PubMed ID: 17402973
[TBL] [Abstract][Full Text] [Related]
52. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
[TBL] [Abstract][Full Text] [Related]
53. Neuron-Specific HuR-Deficient Mice Spontaneously Develop Motor Neuron Disease.
Sun K; Li X; Chen X; Bai Y; Zhou G; Kokiko-Cochran ON; Lamb B; Hamilton TA; Lin CY; Lee YS; Herjan T
J Immunol; 2018 Jul; 201(1):157-166. PubMed ID: 29760195
[TBL] [Abstract][Full Text] [Related]
54. Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms.
Gautam M; Jara JH; Sekerkova G; Yasvoina MV; Martina M; Özdinler PH
Hum Mol Genet; 2016 Mar; 25(6):1074-87. PubMed ID: 26755825
[TBL] [Abstract][Full Text] [Related]
55. Protein aggregation in motor neurone disorders.
Wood JD; Beaujeux TP; Shaw PJ
Neuropathol Appl Neurobiol; 2003 Dec; 29(6):529-45. PubMed ID: 14636160
[TBL] [Abstract][Full Text] [Related]
56. Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1.
Strickland AV; Schabhüttl M; Offenbacher H; Synofzik M; Hauser NS; Brunner-Krainz M; Gruber-Sedlmayr U; Moore SA; Windhager R; Bender B; Harms M; Klebe S; Young P; Kennerson M; Garcia AS; Gonzalez MA; Züchner S; Schule R; Shy ME; Auer-Grumbach M
J Neurol; 2015 Sep; 262(9):2124-34. PubMed ID: 26100331
[TBL] [Abstract][Full Text] [Related]
57. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III.
Jablonka S; Schrank B; Kralewski M; Rossoll W; Sendtner M
Hum Mol Genet; 2000 Feb; 9(3):341-6. PubMed ID: 10655542
[TBL] [Abstract][Full Text] [Related]
58. Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport.
Martin M; Iyadurai SJ; Gassman A; Gindhart JG; Hays TS; Saxton WM
Mol Biol Cell; 1999 Nov; 10(11):3717-28. PubMed ID: 10564267
[TBL] [Abstract][Full Text] [Related]
59. Selective disruption of acetylcholine synthesis in subsets of motor neurons: a new model of late-onset motor neuron disease.
Lecomte MJ; Bertolus C; Santamaria J; Bauchet AL; Herbin M; Saurini F; Misawa H; Maisonobe T; Pradat PF; Nosten-Bertrand M; Mallet J; Berrard S
Neurobiol Dis; 2014 May; 65():102-11. PubMed ID: 24486622
[TBL] [Abstract][Full Text] [Related]
60. Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin.
Festoff BW; D'Andrea MR; Citron BA; Salcedo RM; Smirnova IV; Andrade-Gordon P
Mol Med; 2000 May; 6(5):410-29. PubMed ID: 10952021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
